DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cyclophosphamide (Cyclophosphamide) - Pneumonia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pneumonia (246)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cyclophosphamide where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 246   Next >>

Possible Cyclophosphamide side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: male, weighing 103.1 kg (226.8 pounds)

Reactions: Plasmacytosis, Pneumonia, Mouth Haemorrhage, Pseudomonas Infection, Headache, Disease Progression, Death, Mucosal Inflammation, Pleural Effusion, Depressed Level of Consciousness, Abscess, Lethargy, RIB Fracture

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Indication: Multiple Myeloma

Etoposide
    Indication: Multiple Myeloma

Radiation Therapy NOS
    Indication: Multiple Myeloma

Revlimid
    Indication: Multiple Myeloma

Thalidomide
    Indication: Multiple Myeloma

Velcade
    Indication: Multiple Myeloma

Other drugs received by patient: Bendamustine Hydrochloride; Lenalidomide



Possible Cyclophosphamide side effects in 65 year old female

Reported by a physician from Japan on 2012-08-24

Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)

Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Dosage: 30 mg/m2 x 1/4 week
    Start date: 2011-03-16

Adriamycin PFS
    Dosage: 40 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Carboplatin
    Dosage: 250 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 350 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Etoposide
    Dosage: 100 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Prednisolone
    Dosage: 40 mg/m2 x 1/4 week
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Prednisolone
    Dosage: 1mg/kg x 1/2 week
    Start date: 2011-12-13
    End date: 2011-12-14

Prednisolone
    Dosage: 40 mg/m2 x 1/4 week
    Administration route: Oral
    Start date: 2011-03-16

Prednisolone
    Dosage: 2 mg/m2, 1x/day
    Administration route: Oral
    Start date: 2011-03-24

Ranimustine
    Dosage: 60 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-16

Vincristine Sulfate
    Dosage: 1 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Vindesine Sulfate
    Dosage: 2.4 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium



Possible Cyclophosphamide side effects in male

Reported by a physician from United States on 2012-08-22

Patient: male

Reactions: Rectal Haemorrhage, Constipation, Cardiac Disorder, Hospitalisation, Granulocytopenia, Inappropriate Antidiuretic Hormone Secretion, Thrombocytopenia, Cardiac Failure Congestive, Pneumonia, Anaemia, Pancytopenia, Atrial Fibrillation, Febrile Neutropenia, Syncope, Embolism, Sepsis, Dehydration, Asthenia, Mantle Cell Lymphoma Recurrent, Leukopenia, Deep Vein Thrombosis, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1
    Indication: Mantle Cell Lymphoma

Cyclophosphamide
    Dosage: on day 1
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: on day 1
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: on day 1
    Indication: Mantle Cell Lymphoma

Leukine
    Dosage: on day 9-15; 250 mcg/m2/day
    Indication: Mantle Cell Lymphoma

Leukine
    Dosage: on day 9-15; 250 mcg/m2/day
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone TAB
    Dosage: on days 1-5
    Indication: Mantle Cell Lymphoma

Prednisone TAB
    Dosage: on days 1-5
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: on day 15; as infusion
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Dosage: on day 15; as infusion
    Indication: Mantle Cell Lymphoma

Vincristine
    Dosage: on day 1 (maximum dose: 2mg)
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: on day 1 (maximum dose: 2mg)
    Indication: Mantle Cell Lymphoma



Possible Cyclophosphamide side effects in

Reported by a physician from Netherlands on 2012-08-22

Patient:

Reactions: Pneumonia, Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 4000 mg/m2, unk
    Start date: 2012-02-03
    End date: 2012-02-03

Cyclophosphamide
    Dosage: 500 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2011-12-23
    End date: 2011-12-30

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-12-23
    End date: 2012-01-03

Velcade
    Dosage: 1.3 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2011-12-23
    End date: 2012-01-02

Other drugs received by patient: Tramal / 00599201 /; Acetaminophen; Ascal / 00002702 /; Oxycodone HCL; Fluconazole; Gabapentin; Persantine; Haldol; Omeprazole; Butrans; Fragmin; Esomeprazole Sodium; Pregabalin; Cotrim; Valaciclovir; Hydrochlorothiazide



Possible Cyclophosphamide side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-22

Patient: male

Reactions: Pneumonia, Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Start date: 2011-09-20
    End date: 2011-09-22

Fludarabine Phosphate
    Start date: 2011-09-20
    End date: 2011-09-22

Mabthera
    Start date: 2011-09-20
    End date: 2011-09-20

Other drugs received by patient: Bactrim DS; Valaciclovir



Possible Cyclophosphamide side effects in male

Reported by a consumer/non-health professional from Germany on 2012-08-21

Patient: male, weighing 86.0 kg (189.2 pounds)

Reactions: Pneumonia, Pulmonary Embolism, Cytomegalovirus Infection, Pulmonary Infarction, Lymphoma, Staphylococcal Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1500 mg, qd (day 1)
    Indication: T-Cell Lymphoma
    Start date: 2009-12-07
    End date: 2010-01-11

Doxorubicin HCL
    Dosage: 100 mg, qd (day 1)
    Indication: T-Cell Lymphoma
    Start date: 2009-12-07
    End date: 2010-01-11

Filgrastim
    Dosage: 48 unk, qd (day 1)
    Indication: T-Cell Lymphoma
    Start date: 2009-12-25
    End date: 2010-01-15

Mabcampath
    Dosage: 30 mg, day 4 and 5 of each cycle 1-3
    Indication: T-Cell Lymphoma
    Start date: 2009-12-10
    End date: 2010-01-15

Prednisone
    Dosage: 10 mg, qd (day 1-5)
    Administration route: Oral
    Indication: T-Cell Lymphoma
    Start date: 2009-11-27
    End date: 2010-01-10

Vincristine
    Dosage: 1 mg, qd (day 1)
    Indication: T-Cell Lymphoma
    Start date: 2009-11-26
    End date: 2010-01-11

Other drugs received by patient: Torsemide; Metoprolol Succinate; Heparin; Marcumar; Pantoprazole; Sulfamethoprim



Possible Cyclophosphamide side effects in male

Reported by a physician from Japan on 2012-08-18

Patient: male

Reactions: Drug Eruption, Pneumonia, Oral Candidiasis, Oral Herpes, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Actonel
    Administration route: Oral
    Start date: 2009-05-26
    End date: 2011-10-15

Aspirin
    Administration route: Oral
    Start date: 2006-12-22
    End date: 2011-10-15

Cyclophosphamide
    Administration route: Oral
    Start date: 2009-05-25
    End date: 2011-10-15

Cyclophosphamide
    Administration route: Oral
    Indication: Idiopathic Pulmonary Fibrosis
    Start date: 2006-12-22
    End date: 2007-03-19

Cyclophosphamide
    Administration route: Oral
    Start date: 2008-08-18
    End date: 2009-05-24

Cyclophosphamide
    Administration route: Oral
    Start date: 2007-03-20
    End date: 2008-08-17

Mucodyne
    Administration route: Oral
    Indication: Idiopathic Pulmonary Fibrosis
    Start date: 2007-04-17
    End date: 2011-10-15

Mucosolvan
    Administration route: Oral
    Indication: Idiopathic Pulmonary Fibrosis
    Start date: 2007-10-23
    End date: 2011-10-15

Pirfenidone
    Dosage: 400 mg/am, 400 mg/pm, 600 mg night
    Administration route: Oral
    Start date: 2009-12-14
    End date: 2010-07-07

Pirfenidone
    Dosage: 600 mg/am, 600 mg/pm, 400 mg night
    Administration route: Oral
    Start date: 2010-07-07
    End date: 2011-10-11

Pirfenidone
    Dosage: 200 mg/am, 200 mg/pm, 400 mg night
    Administration route: Oral
    Start date: 2009-11-30
    End date: 2009-12-14

Pirfenidone
    Administration route: Oral
    Indication: Idiopathic Pulmonary Fibrosis
    Start date: 2009-11-16
    End date: 2009-11-30

Povidone Iodine
    Start date: 2009-05-27
    End date: 2011-10-15

Prednisolone
    Administration route: Oral
    Indication: Idiopathic Pulmonary Fibrosis
    Start date: 2006-12-22
    End date: 2011-10-12

Prednisolone

Sulfamethoxazole and Trimethoprim
    Administration route: Oral
    Start date: 2007-03-21
    End date: 2011-10-15

Zolpidem
    Administration route: Oral
    Start date: 2007-01-23
    End date: 2011-10-15

Other drugs received by patient: Neoral; Flomox; Miconazole; Gentamicin Sulfate; Valtrex; Propeto; Neoral; Arasena-A; Olopatadine HCL; Hibidil; Myser



Possible Cyclophosphamide side effects in male

Reported by a physician from Australia on 2012-08-14

Patient: male

Reactions: Pneumonia, Nervous System Disorder, Delirium, Fall

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 3.5714 milligram
    Indication: Multiple Myeloma
    Start date: 2012-05-18
    End date: 2012-05-30

Dexamethasone
    Dosage: 1.4286 milligram
    Indication: Multiple Myeloma
    Start date: 2012-05-18
    End date: 2012-05-30

Prednisolone
    Start date: 2012-05-14
    End date: 2012-06-13

Thalomid
    Dosage: 50 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-18
    End date: 2012-05-30

Other drugs received by patient: Perindopril Erbumine; Coloxyl with Senna; Lamivudine; Amiodarone HCL; Magmin; Morphine; Bisoprolol; Lactulose; Ventolin; Fluticasone Propionate / Salmeterol; Midazolam; Enoxaparin Sodium; Spiriva; Allopurinol; Fentanyl; Aspirin; Moviprep; Acetaminophen



Possible Cyclophosphamide side effects in male

Reported by a individual with unspecified qualification from United States on 2012-08-13

Patient: male, weighing 73.0 kg (160.6 pounds)

Reactions: Pneumonia, Dyspnoea, Hypotension, Malnutrition, Pseudomonas Infection, Atrial Fibrillation, Pulmonary Embolism, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1500 mg

Doxorubicin Hydrochloride
    Dosage: 75 mg

Rituximab (Moab C2b8 Anti Cd20, Chimeric)
    Dosage: 750mg

Vincristine Sulfate
    Dosage: 1.5mg



Possible Cyclophosphamide side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-09

Patient: male

Reactions: Pneumonia, Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Start date: 2011-09-20
    End date: 2011-09-22

Fludarabine Phosphate
    Start date: 2011-09-20
    End date: 2011-09-22

Mabthera
    Start date: 2011-09-20
    End date: 2011-09-20

Other drugs received by patient: Bactrim DS; Valaciclovir



Possible Cyclophosphamide side effects in

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-09

Patient:

Reactions: Dermatitis Allergic, Pneumonia, Angina Pectoris, Febrile Neutropenia, Cognitive Disorder, Hepatitis, Arrhythmia, Interstitial Lung Disease, Gastrointestinal Disorder, Progressive Multifocal Leukoencephalopathy, Cardiac Failure Congestive, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone TAB
    Indication: Diffuse Large B-Cell Lymphoma

Radiotherapy
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Indication: Diffuse Large B-Cell Lymphoma



Possible Cyclophosphamide side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-08

Patient: 64 year old male

Reactions: Pneumonia, Neutropenia, Leukaemia Plasmacytic, Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Indication: Leukaemia Plasmacytic

Cyclophosphamide
    Dosage: 1 g
    Indication: Leukaemia Plasmacytic

Dexamethasone
    Dosage: 40 mg

Dexamethasone
    Dosage: 40 mg
    Indication: Leukaemia Plasmacytic

Lenalidomide
    Dosage: 25 mg
    Indication: Leukaemia Plasmacytic



Possible Cyclophosphamide side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient: male, weighing 98.0 kg (215.6 pounds)

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
ABT-263
    Administration route: Oral
    Start date: 2010-12-14

ABT-263
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2010-11-20

Cyclophosphamide
    Start date: 2010-11-17
    End date: 2010-11-19

Cyclophosphamide
    Start date: 2011-01-11

Fludarabine Phosphate
    Start date: 2010-11-17
    End date: 2010-11-19

Fludarabine Phosphate
    Start date: 2010-12-15

Rituximab
    Start date: 2010-11-15
    End date: 2010-11-16

Rituximab
    Start date: 2010-12-15

Other drugs received by patient: Ondansetron; Ondansetron; Acetaminophen; Acetaminophen; Diphenhydramine HCL; Dozol; Ondansetron; Ondansetron; Ondansetron; Diphenhydramine HCL; Lorazepam; Ondansetron; Ondansetron; Acetaminophen; Acetaminophen; Pegfilgrastim; Allopurinol; Diphenhydramine HCL; Ranitidine; Dexamethasone Phosphate; Dexamethasone Phosphate; Pegfilgrastim; Candesartan Cilexetil; Fluconazole; Acetaminophen; Ranitidine; Albuterol Sulate; Acyclovir; Pegfilgrastim; Hydrocortisone; Prochlorperazine; Acetaminophen; Ranitidine; Aluminium Chloride; Ondansetron; Ondansetron; Diphenhydramine HCL; Diphenhydramine HCL; Ranitidine; Dexamethasone Phosphate; Bactrim; Loperamide HCL; Magnesium Hydroxide TAB; Atorvastatin Calcium



Possible Cyclophosphamide side effects in 74 year old female

Reported by a consumer/non-health professional from United Kingdom on 2012-08-03

Patient: 74 year old female

Reactions: Drug Eruption, Pneumonia, Neutropenic Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Administration route: Oral
    Start date: 2012-06-01
    End date: 2012-06-08

Cyclophosphamide
    Administration route: Oral
    End date: 2012-07-13

Dexamethasone
    Administration route: Oral
    End date: 2012-07-09

Dexamethasone
    Administration route: Oral
    Start date: 2012-06-01
    End date: 2012-06-04

Revlimid
    Administration route: Oral
    End date: 2012-07-18

Revlimid
    Administration route: Oral
    Start date: 2012-06-01
    End date: 2012-06-21

Other drugs received by patient: Allopurinol; Whole Blood



Possible Cyclophosphamide side effects in

Reported by a physician from Italy on 2012-07-20

Patient:

Reactions: Pneumonia, Respiratory Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 75% reduced r-chop

Cyclophosphamide
    Dosage: on day 2
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Dosage: 75% reduced r-chop

Doxorubicin HCL
    Dosage: on day 2
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: 75% reduced r-chop
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone
    Dosage: on days 1-5
    Administration route: Oral

Rituximab
    Dosage: on day 1

Rituximab
    Dosage: 75% reduced r-chop
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: 75% reduced r-chop

Vincristine
    Dosage: on day 2, upto a maximum dose of 2 mg
    Indication: Diffuse Large B-Cell Lymphoma



Possible Cyclophosphamide side effects in 66 year old male

Reported by a physician from Japan on 2012-07-20

Patient: 66 year old male

Reactions: Pneumonia, Interstitial Lung Disease

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Dosage: 40 mg/m2, unk
    Start date: 2010-12-22
    End date: 2010-12-22

Adriamycin PFS
    Dosage: 30 mg/m2, unk
    Start date: 2010-10-14
    End date: 2010-10-14

Adriamycin PFS
    Dosage: 30 mg/m2, unk
    Start date: 2010-11-24
    End date: 2010-11-24

Adriamycin PFS
    Dosage: 30 mg/m2, unk
    Start date: 2010-12-29
    End date: 2010-12-29

Adriamycin PFS
    Dosage: 40 mg/m2, unk
    Start date: 2010-11-16
    End date: 2010-11-16

Adriamycin PFS
    Dosage: 40 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-07
    End date: 2010-10-07

Allopurinol
    Dosage: 100 mg, 3x/day
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2011-07-19

Allopurinol
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Hyperuricaemia
    End date: 2011-01-20

Amlodipine
    Dosage: 5 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-10-08
    End date: 2011-02-17

Baraclude
    Dosage: 0.5 mg, 1/2day
    Administration route: Oral
    Indication: Hepatitis B
    Start date: 2010-06-29
    End date: 2011-07-19

Carboplatin
    Dosage: 250 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-26
    End date: 2010-12-08

Cefazolin Sodium
    Dosage: unk
    Administration route: Oral
    Indication: Proctitis
    Start date: 2010-10-22
    End date: 2011-02-17

Cyclophosphamide
    Dosage: 350 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-07
    End date: 2010-12-22

Cymerin
    Dosage: 60 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-14
    End date: 2010-12-29

Cytarabine
    Dosage: 40 mg, daily
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-11-18
    End date: 2010-11-18

Diflucan
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Antifungal Prophylaxis
    End date: 2011-01-11

Diflucan
    Dosage: unk
    Start date: 2011-01-19
    End date: 2011-01-28

Etoposide
    Dosage: 100 mg/m2, 3x/day
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-26
    End date: 2010-12-08

Fentanyl
    Dosage: unk
    Indication: Stomatitis
    Start date: 2011-01-02
    End date: 2011-01-19

Fildesin
    Dosage: 2.4 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-26
    End date: 2010-12-08

KW-0761
    Dosage: 1 mg/kg, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-08
    End date: 2010-12-21

Lansoprazole
    Dosage: 15 mg, 1x/day
    Administration route: Oral
    Start date: 2011-05-26
    End date: 2011-07-19

Lansoprazole
    Dosage: 15 mg, 1x/day
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease
    End date: 2011-02-17

Lipidil
    Dosage: 100 df, 1x/day
    Administration route: Oral
    Indication: Hyperlipidaemia
    End date: 2011-01-26

Lyrica
    Dosage: 75 mg, 1x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-29
    End date: 2011-07-19

Magmitt
    Dosage: unk
    Administration route: Oral
    Indication: Constipation
    Start date: 2011-01-07
    End date: 2011-01-10

Meropenem
    Dosage: 0.5 g, 2x/day
    Indication: Pneumonia
    Start date: 2011-01-07
    End date: 2011-01-24

Meropenem
    Dosage: 1 g, 3x/day
    Start date: 2011-07-04
    End date: 2011-07-15

Methotrexate Sodium
    Dosage: 15 mg, daily
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-11-18
    End date: 2010-11-18

Oncovin
    Dosage: 1 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-07
    End date: 2010-12-22

Pantosin
    Dosage: unk
    Administration route: Oral
    Indication: Constipation
    Start date: 2011-01-07
    End date: 2011-01-10

Prednisolone
    Dosage: 40 mg/m2, unk
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-07
    End date: 2010-12-29

Prednisolone
    Dosage: 10 mg, daily
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-11-18
    End date: 2010-11-18

Sulfamethoxazole and Trimethoprim
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Start date: 2011-07-15

Sulfamethoxazole and Trimethoprim
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Indication: Antifungal Prophylaxis
    End date: 2011-01-28

Vancomycin
    Dosage: 0.5 g, 2x/day
    Start date: 2011-01-07
    End date: 2011-01-17

Zovirax
    Dosage: unk
    Start date: 2011-06-30
    End date: 2011-07-08

Zovirax
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2011-01-28

Zovirax
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Start date: 2011-07-12
    End date: 2011-07-19

Other drugs received by patient: Vfend; Targocid; Slow-K; Ciprofloxacin HCL



Possible Cyclophosphamide side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient:

Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 500 milligram/sq. meter
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Revlimid
    Dosage: 15 milligram
    Administration route: Oral

Velcade
    Dosage: 1.3 milligram/sq. meter
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 milligram/sq. meter



Possible Cyclophosphamide side effects in female

Reported by a physician from France on 2012-07-18

Patient: female, weighing 40.0 kg (88.0 pounds)

Reactions: Pneumonia, General Physical Health Deterioration, Febrile Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Istodax
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-12

Prednisone
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13

Vincristine
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-10-27
    End date: 2012-04-13



Possible Cyclophosphamide side effects in 65 year old female

Reported by a physician from Japan on 2012-07-16

Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)

Reactions: Pneumonia, Interstitial Lung Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 250 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 350 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Doxorubicin Hydrochloride
    Dosage: 30 mg/m2 x 1/4 week
    Start date: 2011-03-16

Doxorubicin Hydrochloride
    Dosage: 40 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Etopophos Preservative Free
    Dosage: 100 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Prednisolone
    Dosage: 40 mg/m2 x 1/4 week
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Prednisolone
    Dosage: 2 mg/m2, 1x/day
    Administration route: Oral
    Start date: 2011-03-24

Prednisolone
    Dosage: 1mg/kg x 1/2 week
    Start date: 2011-12-13
    End date: 2011-12-14

Prednisolone
    Dosage: 40 mg/m2 x 1/4 week
    Administration route: Oral
    Start date: 2011-03-16

Ranimustine
    Dosage: 60 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-16

Vincristine Sulfate
    Dosage: 1 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Vindesine Sulfate
    Dosage: 2.4 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Other drugs received by patient: Sulfamethoxazole and Trimethoprim; Alendronate Sodium; Magmitt; Mucosolvan; Zovirax; Diflucan; Ciprofloxacin HCL; Olopatadine HCL; Cefazolin Sodium; Zolpidem; Diflucan; Lansoprazole



Possible Cyclophosphamide side effects in male

Reported by a physician from Japan on 2012-07-16

Patient: male

Reactions: Drug Eruption, Pneumonia, Oral Candidiasis, Oral Herpes, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Actonel
    Administration route: Oral
    Start date: 2009-05-26

Aspirin
    Administration route: Oral
    Start date: 2006-12-22

Cyclophosphamide
    Administration route: Oral
    Start date: 2009-05-25

Cyclophosphamide
    Administration route: Oral
    Indication: Idiopathic Pulmonary Fibrosis
    Start date: 2006-12-22
    End date: 2007-03-19

Cyclophosphamide
    Administration route: Oral
    Start date: 2008-08-18
    End date: 2009-05-24

Cyclophosphamide
    Administration route: Oral
    Start date: 2007-03-20
    End date: 2008-08-17

Mucodyne
    Administration route: Oral
    Start date: 2007-04-17

Mucosolvan
    Administration route: Oral
    Start date: 2007-10-23

Pirfenidone
    Administration route: Oral
    Start date: 2009-11-30
    End date: 2009-12-14

Pirfenidone
    Administration route: Oral
    Start date: 2009-12-14
    End date: 2010-07-07

Pirfenidone
    Administration route: Oral
    Indication: Idiopathic Pulmonary Fibrosis
    Start date: 2009-11-16
    End date: 2009-11-30

Pirfenidone
    Administration route: Oral
    Start date: 2010-07-07

Povidone Iodine
    Start date: 2009-05-27

Prednisolone
    Administration route: Oral
    Indication: Idiopathic Pulmonary Fibrosis
    Start date: 2006-12-22
    End date: 2011-10-12

Prednisolone

Sulfamethoxazole and Trimethoprim
    Administration route: Oral
    Start date: 2007-03-21

Zolpidem
    Administration route: Oral
    Start date: 2007-01-23

Other drugs received by patient: Olopatadine HCL; Valtrex; Gentamicin Sulfate; Propeto; Miconazole; Neoral; Flomax; Hibidil; Arasena-A; Neoral



Possible Cyclophosphamide side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-07-13

Patient: 68 year old female

Reactions: Pneumonia, Fungal Infection, Paraneoplastic Pemphigus, Cytomegalovirus Infection, Neutropenia, Herpes Zoster

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: unk, 1 course
    Indication: Chronic Lymphocytic Leukaemia Recurrent

Cyclophosphamide
    Dosage: unk, 2nd course

Fludara
    Dosage: unk, 1 course
    Indication: Chronic Lymphocytic Leukaemia Recurrent

Fludara
    Dosage: unk, 2 course

Mabcampath
    Dosage: 30 mg, 3x/w
    Indication: Paraneoplastic Pemphigus

Other drugs received by patient: Prednisone; Prednisone; Bendamustine Hydrochloride; Prednisone; Rituximab



Possible Cyclophosphamide side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-07-09

Patient: 68 year old female

Reactions: Pneumonia, Fungal Infection, Paraneoplastic Pemphigus, Cytomegalovirus Infection, Neutropenia, Herpes Zoster

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: unk, 2nd course

Cyclophosphamide
    Dosage: unk, 1 course
    Indication: Chronic Lymphocytic Leukaemia Recurrent

Fludara
    Dosage: unk, 1 course
    Indication: Chronic Lymphocytic Leukaemia Recurrent

Fludara
    Dosage: unk, 2 course

Mabcampath
    Dosage: 30 mg, 3x/w
    Indication: Paraneoplastic Pemphigus
    Start date: 2009-02-01

Other drugs received by patient: Prednisone; Prednisone; Bendamustine Hydrochloride; Prednisone; Rituximab



Possible Cyclophosphamide side effects in male

Reported by a lawyer from Denmark on 2012-07-09

Patient: male

Reactions: Pneumonia, Respiratory Failure, Septic Shock, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-07-14

Mabthera
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-07-14

Oncovin
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-07-14

Prednisolone
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-07-14



Possible Cyclophosphamide side effects in male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-05

Patient: male

Reactions: Pneumonia, Respiratory Failure, Septic Shock, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Start date: 2011-07-14

Mabthera
    Start date: 2011-07-14

Oncovin
    Start date: 2011-07-14

Prednisolone
    Start date: 2011-07-14



Possible Cyclophosphamide side effects in

Reported by a physician from Hungary on 2012-07-05

Patient:

Reactions: Pneumonia, Respiratory Failure

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Lymphoma

Doxorubicin HCL
    Indication: Lymphoma

Prednisone TAB
    Indication: Lymphoma

Vincristine
    Indication: Lymphoma



Possible Cyclophosphamide side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient: female

Reactions: Pneumonia

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: (100 mg/m2 on days 1-14, oral
    Administration route: Oral
    Indication: Breast Cancer

Doxorubicin HCL
    Dosage: (30 mg/m2 on days 1 and 8, intravenous (not otherwise specified)
    Indication: Breast Cancer

Fluorouracil
    Dosage: (500mg/m2 on days 1 and 8, intravenous (not otherwise specified))
    Indication: Breast Cancer



Possible Cyclophosphamide side effects in 58 year old male

Reported by a physician from Japan on 2012-06-27

Patient: 58 year old male, weighing 63.0 kg (138.6 pounds)

Reactions: Pneumonia, Bone Marrow Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Adriamycin PFS
    Dosage: 80 mg, 1x/day
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-16
    End date: 2009-01-16

Cyclophosphamide
    Dosage: 1250 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-16
    End date: 2009-01-16

Methotrexate Sodium
    Dosage: 15 mg, weekly
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-16
    End date: 2009-01-23

Prednisolone
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-16
    End date: 2009-01-20

Prednisolone
    Dosage: 20 mg, weekly
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-16
    End date: 2009-01-23

Rituximab
    Dosage: 600 mg, 1x/day
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-16
    End date: 2009-01-16

Vincristine Sulfate
    Dosage: 2 mg, 1x/day
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2009-01-16
    End date: 2009-01-16

Other drugs received by patient: Neutrogin; Neutrogin



Possible Cyclophosphamide side effects in female

Reported by a physician from Italy on 2012-06-26

Patient: female

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-04-12
    End date: 2012-05-03

Doxorubicin HCL
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-04-12
    End date: 2012-05-03

Vincristine
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-04-12
    End date: 2012-05-03

Other drugs received by patient: Pantoprazole



Possible Cyclophosphamide side effects in

Reported by a individual with unspecified qualification from Taiwan, Province of China on 2012-06-25

Patient:

Reactions: Gastrointestinal Haemorrhage, Pneumonia, Hepatitis Acute, Urinary Tract Infection, Febrile Neutropenia, Herpes Zoster, Fungaemia, Bacteraemia, Anal Abscess, Hepatitis B, Cardiac Failure Congestive

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Epirubicin Hydrochloride
    Indication: Diffuse Large B-Cell Lymphoma

Mabthera
    Indication: Diffuse Large B-Cell Lymphoma

Prednisone TAB
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma

Vincristine
    Dosage: 1.4 mg/m2 (maximum 2 mg)
    Indication: Diffuse Large B-Cell Lymphoma



Possible Cyclophosphamide side effects in 51 year old female

Reported by a physician from Italy on 2012-06-21

Patient: 51 year old female

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1100 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-04-12
    End date: 2012-05-03

Doxorubicin HCL
    Dosage: 75 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-04-12
    End date: 2012-05-03

Vincristine
    Dosage: 2 mg, cyclic
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-04-12
    End date: 2012-05-03

Other drugs received by patient: Pantoprazole



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014